Since beginning operations in 1997, Probiotec has quickly emerged as a leading manufacturer, marketer and distributer of a diverse, high quality range of prescription and over-the-counter (OTC) pharmaceuticals, complementary medicines and specialty ingredients.

Now listed on the Australian Stock Exchange (ASX), this Australian owned and internationally operated company has built an enviable reputation for developing innovative new pharmaceutical, nutraceutical and cosmeceutical products which not only address researched consumer needs, but also succeed in gaining the clinical approvals necessary to respond rapidly to market opportunities, both locally and internationally.